493 related articles for article (PubMed ID: 23644528)
1. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
Berry WL; Janknecht R
Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
[TBL] [Abstract][Full Text] [Related]
2. Advances in histone demethylase KDM4 as cancer therapeutic targets.
Lee DH; Kim GW; Jeon YH; Yoo J; Lee SW; Kwon SH
FASEB J; 2020 Mar; 34(3):3461-3484. PubMed ID: 31961018
[TBL] [Abstract][Full Text] [Related]
3. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
Chin YW; Han SY
Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
[TBL] [Abstract][Full Text] [Related]
4. The role of the histone demethylase KDM4A in cancer.
Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
[TBL] [Abstract][Full Text] [Related]
5. Continual removal of H3K9 promoter methylation by Jmjd2 demethylases is vital for ESC self-renewal and early development.
Pedersen MT; Kooistra SM; Radzisheuskaya A; Laugesen A; Johansen JV; Hayward DG; Nilsson J; Agger K; Helin K
EMBO J; 2016 Jul; 35(14):1550-64. PubMed ID: 27266524
[TBL] [Abstract][Full Text] [Related]
6. Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells.
Agger K; Miyagi S; Pedersen MT; Kooistra SM; Johansen JV; Helin K
Genes Dev; 2016 Jun; 30(11):1278-88. PubMed ID: 27257215
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.
Young LC; Hendzel MJ
Biochem Cell Biol; 2013 Dec; 91(6):369-77. PubMed ID: 24219278
[TBL] [Abstract][Full Text] [Related]
8. Unravelling KDM4 histone demethylase inhibitors for cancer therapy.
Baby S; Gurukkala Valapil D; Shankaraiah N
Drug Discov Today; 2021 Aug; 26(8):1841-1856. PubMed ID: 34051367
[TBL] [Abstract][Full Text] [Related]
9. KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor.
Chu CH; Wang LY; Hsu KC; Chen CC; Cheng HH; Wang SM; Wu CM; Chen TJ; Li LT; Liu R; Hung CL; Yang JM; Kung HJ; Wang WC
J Med Chem; 2014 Jul; 57(14):5975-85. PubMed ID: 24971742
[TBL] [Abstract][Full Text] [Related]
10. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family.
Hillringhaus L; Yue WW; Rose NR; Ng SS; Gileadi C; Loenarz C; Bello SH; Bray JE; Schofield CJ; Oppermann U
J Biol Chem; 2011 Dec; 286(48):41616-41625. PubMed ID: 21914792
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of JMJD2 family genes in silico.
Katoh M; Katoh M
Int J Oncol; 2004 Jun; 24(6):1623-8. PubMed ID: 15138608
[TBL] [Abstract][Full Text] [Related]
12. TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
Chandhasin C; Dang V; Perabo F; Del Rosario J; Chen YK; Filvaroff E; Stafford JA; Clarke M
Anticancer Drugs; 2023 Nov; 34(10):1122-1131. PubMed ID: 37067993
[TBL] [Abstract][Full Text] [Related]
13. Reader domain specificity and lysine demethylase-4 family function.
Su Z; Wang F; Lee JH; Stephens KE; Papazyan R; Voronina E; Krautkramer KA; Raman A; Thorpe JJ; Boersma MD; Kuznetsov VI; Miller MD; Taverna SD; Phillips GN; Denu JM
Nat Commun; 2016 Nov; 7():13387. PubMed ID: 27841353
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).
Leurs U; Clausen RP; Kristensen JL; Lohse B
Bioorg Med Chem Lett; 2012 Sep; 22(18):5811-3. PubMed ID: 22917519
[TBL] [Abstract][Full Text] [Related]
15. KDM4B: A promising oncology therapeutic target.
Ni F; Tang H; Cheng S; Yu Y; Yuan Z; Chen Y; Zhang E; Wang X
Cancer Sci; 2024 Jan; 115(1):8-16. PubMed ID: 37923555
[TBL] [Abstract][Full Text] [Related]
16. KDM4 Demethylases: Structure, Function, and Inhibitors.
Jiang Y; Liu L; Yang ZQ
Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.
Ipenberg I; Guttmann-Raviv N; Khoury HP; Kupershmit I; Ayoub N
J Biol Chem; 2013 May; 288(21):14681-7. PubMed ID: 23589305
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase JMJD2B/KDM4B regulates transcriptional program via distinctive epigenetic targets and protein interactors for the maintenance of trophoblast stem cells.
Mak KH; Lam YM; Ng RK
Sci Rep; 2021 Jan; 11(1):884. PubMed ID: 33441614
[TBL] [Abstract][Full Text] [Related]
19. Diversity within the JMJD2 histone demethylase family.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Feb; 353(4):973-7. PubMed ID: 17207460
[TBL] [Abstract][Full Text] [Related]
20. KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes.
Duan L; Rai G; Roggero C; Zhang QJ; Wei Q; Ma SH; Zhou Y; Santoyo J; Martinez ED; Xiao G; Raj GV; Jadhav A; Simeonov A; Maloney DJ; Rizo J; Hsieh JT; Liu ZP
Chem Biol; 2015 Sep; 22(9):1185-96. PubMed ID: 26364928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
